Luan and colleagues recently reported that ALMS1-IT1 promoted the malignant progression of lung adenocarcinoma through AVL9-mediated activation of the cyclin-dependent kinase pathway (73). This evidence concerns the gene AVL9 and lung adenocarcinoma.